-+ 0.00%
-+ 0.00%
-+ 0.00%

Tevogen Bio Announces Promising Clinical Trial Results for TVGN 489, Aiming to Enhance COVID-19 Immunotherapy for Vulnerable Populations

Reuters·09/03/2025 20:15:29

Please log in to view news